News for Healthier Living

Study: Cancer's Clues in the Bloodstream Reveal the Role Androgen Receptor Alterations Play in Metastatic Prostate Cancer

Serial liquid biopsies showed that emerging AR alterations are linked to poorer outcomes in metastatic prostate cancer. Study suggests that a single genomic test at dx is no longer sufficient for managing advanced prostate cancer; supports real-time molecular testing to guide more personalized care.

February 26, 2026


February 26 2026

February 25 2026

February 24 2026

February 23 2026

February 22 2026

February 21 2026

February 20 2026

February 19 2026

February 18 2026

February 17 2026

February 16 2026

February 15 2026

February 14 2026

February 13 2026

February 12 2026